Covaxin neutralises double mutant strain: ICMR
Team Udayavani, Apr 21, 2021, 2:17 PM IST
New Delhi: Indigenously developed COVID-19 vaccine, Covaxin, neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday.
Bharat Biotech’s Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe with another 60 in the process.
“ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well,” the ICMR tweeted.
ICMR-National Institute of Virology has successfully isolated and cultured multiple variants of concern of SARS-CoV-2 virus: B.1.1.7 (the UK variant), B.1.1.28 (Brazil variant ) and B.1.351 (South Africa variant).
ICMR-NIV has demonstrated the neutralisation potential of Covaxin against the UK variant and Brazil variant, the apex health research body said.
ICMR-NIV recently has been successful in isolating and culturing the double mutant strain B.1.617 SARS-CoV-2 identified in certain regions of India and several other countries, the ICMR stated.
“Covaxin has been found to effectively neutralise the double mutant strain as well,” it said.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Kerala Police engages in gun battle with Maoists in Wayanad
IndiGo sets up desk for passengers with special needs at Delhi airport
49 Lok Sabha, 318 Assembly polls nominations withdrawn in Andhra Pradesh: CEO
‘Who would be responsible for heart attack deaths’: Opposition slam BJP over Covishield row
‘Shehzada’ dig: 3 generations of Nehru-Gandhi family sacrificed themselves for country, says Sharad Pawar
MUST WATCH
Latest Additions
Kerala Police engages in gun battle with Maoists in Wayanad
IndiGo sets up desk for passengers with special needs at Delhi airport
T20 World Cup: Sunil Gavaskar feels Rinku Singh’s poor IPL form could be reason behind exclusion from main squad
49 Lok Sabha, 318 Assembly polls nominations withdrawn in Andhra Pradesh: CEO
‘Who would be responsible for heart attack deaths’: Opposition slam BJP over Covishield row